Literature DB >> 18784141

Right ventricular function in scleroderma-related pulmonary hypertension.

A Vonk Noordegraaf1, R Naeije.   

Abstract

SSc-associated pulmonary arterial hypertension (PAH) has a poorer prognosis than that of other types of pulmonary hypertension. Recent echocardiographic and haemodynamic studies suggest that right ventriculer (RV) pump function and filling characteristics are altered in SSc-PAH as compared with idiopathic PAH. This could be explained by intrinsic myocardial involvement of the disease, related to abnormal collagen deposition, also observed in the left ventricle, or an increased vulnerability to ischaemia due to coronary vasculopathy, abnormal collagen cross-linking and altered myocyte function. It is also possible that a relatively more important decrease in pulmonary arterial compliance as evidenced by recently reported increased characteristic impedance measurements, would contribute to RV-arterial decoupling. More pathological, imaging and haemodynamic studies are needed for a better understanding for relatively more important vulnerability of the RV in SSc-PAH.

Entities:  

Mesh:

Year:  2008        PMID: 18784141     DOI: 10.1093/rheumatology/ken284

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

Review 1.  [Pulmonary arterial hypertension in collagenoses].

Authors:  M Claussen; G Riemekasten; M M Hoeper
Journal:  Z Rheumatol       Date:  2009-10       Impact factor: 1.372

2.  Increased right ventricular Septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass.

Authors:  Jens Vogel-Claussen; Monda L Shehata; Dirk Lossnitzer; Jan Skrok; Sukhminder Singh; Danielle Boyce; Noah Lechtzin; Reda E Girgis; Stephen C Mathai; Joao A Lima; David A Bluemke; Paul M Hassoun
Journal:  Invest Radiol       Date:  2011-09       Impact factor: 6.016

Review 3.  [Pulmonary hypertension in connective tissue disease].

Authors:  E I Schwarz; S Ulrich
Journal:  Z Rheumatol       Date:  2018-04       Impact factor: 1.372

Review 4.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

Review 5.  Imaging lung disease in systemic sclerosis.

Authors:  Diane Strollo; Jonathan Goldin
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

6.  Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion.

Authors:  Jianliang Zhang; Hanbo Hu; Nadia L Palma; Jeffrey K Harrison; Kamal K Mubarak; Robin D Carrie; Hassan Alnuaimat; Xiaoqiang Shen; Defang Luo; Jawaharlal M Patel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-09-21       Impact factor: 5.464

7.  Nicorandil prevents right ventricular remodeling by inhibiting apoptosis and lowering pressure overload in rats with pulmonary arterial hypertension.

Authors:  Xiang-Rong Zuo; Qiang Wang; Quan Cao; Yan-Zhe Yu; Hui Wang; Li-Qing Bi; Wei-Ping Xie; Hong Wang
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

8.  The Prognostic Value of Right Atrial and Right Ventricular Functional Parameters in Systemic Sclerosis.

Authors:  Jacqueline L Vos; Steele C Butcher; Federico Fortuni; Xavier Galloo; Laura Rodwell; Madelon C Vonk; Jeroen J Bax; Sander I van Leuven; Jeska K de Vries-Bouwstra; Miranda Snoeren; Saloua El Messaoudi; Nina A Marsan; Robin Nijveldt
Journal:  Front Cardiovasc Med       Date:  2022-03-17

Review 9.  Cardiopulmonary coupling in chronic obstructive pulmonary disease: the role of imaging.

Authors:  Farbod N Rahaghi; Edwin J R van Beek; George R Washko
Journal:  J Thorac Imaging       Date:  2014-03       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.